SelvasAI Expands into Medical, Education, and Robot Markets... "Fostering New Businesses"

"Enhancing Corporate Value, Committed to Shareholder Benefits"
Decision on 78.8 Billion Won Capital Increase

AI specialist company Selvas AI announced on the 10th that it will increase investments in research and development (R&D) in new businesses such as healthcare and education to enhance competitiveness and grow its performance.

Mincheol Kwak, CEO of Selvas AI, said, "We have been discovering and nurturing new businesses to enhance corporate value through growth," adding, "We will strive to quickly realize AI digital transformation in the fields of AI healthcare, AI education, and metarobility to improve corporate value and lead to shareholder benefits." Metarobility is a compound word combining metaverse, robots, and mobility.

In the AI healthcare sector, the company is already conducting a 'military mobile remote medical service' business based on its own software technology and Selvas Healthcare's hardware technology. By securing related telemedicine solutions, video equipment, and global AI company technologies, it plans to expand from military remote medical services to the civilian telemedicine market.

In the AI education sector, Selvas AI possesses recognition software technology, intelligent learning analysis tools, and AI digital textbook production solutions. The plan is to expand into the personalized education market through securing educational content and AI tutors.

Metarobility is the field where voice recognition-based conversational services are most needed. Through cooperation with robot companies, automobile manufacturers, and metaverse service companies, Selvas AI plans to provide hyper-personalized services not only through conversational services but also by securing global IP independently.

Selvas AI, which supplies related technologies to global automobile manufacturers, envisions opening the era of conversational AI robots and automobiles by utilizing voice intelligence technology applied with ultra-large AI.

Meanwhile, on the 7th, the company decided on a paid-in capital increase by shareholder allocation worth approximately 78.8 billion KRW. The purpose of the capital increase is to grow performance through the expansion of new AI convergence businesses such as AI telemedicine and new AI medical diagnostic product development.